electroCore, Inc.

ECOR Nasdaq CIK: 0001560258

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 200 FORGE WAY, ROCKAWAY, NJ, 07866
Mailing Address 200 FORGE WAY, ROCKAWAY, NJ, 07866
Phone 973-290-0097
Fiscal Year End 1231
EIN 203454976

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 20, 2026 View on SEC
8-K Current report of material events March 19, 2026 View on SEC
10-K Annual financial report March 19, 2026 View on SEC
4 Insider stock transaction report January 28, 2026 View on SEC
4 Insider stock transaction report January 28, 2026 View on SEC
8-K Current report of material events January 20, 2026 View on SEC
4 Insider stock transaction report December 5, 2025 View on SEC
4 Insider stock transaction report December 3, 2025 View on SEC
4 Insider stock transaction report November 14, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 13, 2025 View on SEC

Annual Reports

10-K March 19, 2026
  • Successful diversification into chronic pain and consumer wellness markets through NeuroMetrix acquisition.
  • Launched next-generation gammaCore Emerald in early 2023, enhancing core product offering with improved features.
View Analysis

Material Events

8-K Financial Distress March 19, 2026
High Impact
  • Record Sales Growth: $32.0 million in 2025, a 27% increase from 2024.
  • Strong Product Demand: Wellness products grew 97%, U.S. prescription business grew 25%.
View Analysis

Insider Trading

SELL 2 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.